FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2009781900> ?p ?o ?g. }

• W2009781900 endingPage "740" @default.
• W2009781900 startingPage "732" @default.
• W2009781900 abstract "BackgroundSerine protease inhibitors such as aprotinin reduce perioperative blood loss and may improve postpump cardiac performance owing to their anti-inflammatory properties. After the “aprotinin era,” we investigated the efficacy of the novel synthetic serine protease inhibitors CU-2010 with improved coagulatory and anti-inflammatory profile on blood loss and reperfusion injury in a canine model.MethodsThirty-six dogs were divided into 6 groups: control, aprotinin (n = 8; Hammersmith scheme), and CU-2010 (0.5, 0.83, 1.25, and 1.66 mg/kg). All animals underwent 90 minutes of cardiopulmonary bypass with 60 minutes of hypothermic cardioplegic arrest. End points were blood loss during the first 2 hours after application of protamine, as well as recovery of myocardial contractility (slope of the end-systolic pressure–volume relationship, coronary blood flow, and vascular reactivity.ResultsCU-2010 dose-dependently reduced blood loss to a degree comparable with that of aprotinin at lower doses and even further improved at higher doses (control/aprotinin/CU-2010 in increasing doses: 142 ± 13, 66 ± 17, 95 ± 16, 57 ± 17, 46 ± 3, and 13 ± 4 mL; P < .05). Whereas aprotinin did not influence myocardial function, CU-2010 improved the recovery of end-systolic pressure–volume relationship (control 60 ± 6 mg kg vs aprotinin 73 ± 7 mg/kg vs CU-2010 1.66 mg/kg; 102% ± 8%; P < .05). Coronary blood flow (52 ± 4 vs 88 ± 7 vs 96 ± 7; P < .05) and response to acetylcholine (44% ± 6% vs 77% ± 7% vs 81% ± 6%; P < .05) were improved by both aprotinin and CU-2010.ConclusionsThe novel serine protease inhibitor CU-2010 significantly reduced blood loss after cardiac surgery comparable with aprotinin. Furthermore, an additionally improved anti-inflammatory profile led to a significantly improved postischemic recovery of myocardial and endothelial function. Serine protease inhibitors such as aprotinin reduce perioperative blood loss and may improve postpump cardiac performance owing to their anti-inflammatory properties. After the “aprotinin era,” we investigated the efficacy of the novel synthetic serine protease inhibitors CU-2010 with improved coagulatory and anti-inflammatory profile on blood loss and reperfusion injury in a canine model. Thirty-six dogs were divided into 6 groups: control, aprotinin (n = 8; Hammersmith scheme), and CU-2010 (0.5, 0.83, 1.25, and 1.66 mg/kg). All animals underwent 90 minutes of cardiopulmonary bypass with 60 minutes of hypothermic cardioplegic arrest. End points were blood loss during the first 2 hours after application of protamine, as well as recovery of myocardial contractility (slope of the end-systolic pressure–volume relationship, coronary blood flow, and vascular reactivity. CU-2010 dose-dependently reduced blood loss to a degree comparable with that of aprotinin at lower doses and even further improved at higher doses (control/aprotinin/CU-2010 in increasing doses: 142 ± 13, 66 ± 17, 95 ± 16, 57 ± 17, 46 ± 3, and 13 ± 4 mL; P < .05). Whereas aprotinin did not influence myocardial function, CU-2010 improved the recovery of end-systolic pressure–volume relationship (control 60 ± 6 mg kg vs aprotinin 73 ± 7 mg/kg vs CU-2010 1.66 mg/kg; 102% ± 8%; P < .05). Coronary blood flow (52 ± 4 vs 88 ± 7 vs 96 ± 7; P < .05) and response to acetylcholine (44% ± 6% vs 77% ± 7% vs 81% ± 6%; P < .05) were improved by both aprotinin and CU-2010. The novel serine protease inhibitor CU-2010 significantly reduced blood loss after cardiac surgery comparable with aprotinin. Furthermore, an additionally improved anti-inflammatory profile led to a significantly improved postischemic recovery of myocardial and endothelial function." @default.
• W2009781900 created "2016-06-24" @default.
• W2009781900 creator A5010710044 @default.
• W2009781900 creator A5011287213 @default.
• W2009781900 creator A5026657861 @default.
• W2009781900 creator A5036332989 @default.
• W2009781900 creator A5041469816 @default.
• W2009781900 creator A5053079459 @default.
• W2009781900 creator A5058653910 @default.
• W2009781900 creator A5072582612 @default.
• W2009781900 creator A5073141203 @default.
• W2009781900 creator A5091801351 @default.
• W2009781900 date "2010-03-01" @default.
• W2009781900 modified "2023-10-16" @default.
• W2009781900 title "The novel synthetic serine protease inhibitor CU-2010 dose-dependently reduces postoperative blood loss and improves postischemic recovery after cardiac surgery in a canine model" @default.
• W2009781900 cites W127580824 @default.
• W2009781900 cites W1951513130 @default.
• W2009781900 cites W1968215909 @default.
• W2009781900 cites W1978691495 @default.
• W2009781900 cites W1983291887 @default.
• W2009781900 cites W1987652595 @default.
• W2009781900 cites W1990230828 @default.
• W2009781900 cites W1996462600 @default.
• W2009781900 cites W2001747118 @default.
• W2009781900 cites W2002504775 @default.
• W2009781900 cites W2003356582 @default.
• W2009781900 cites W2009699612 @default.
• W2009781900 cites W2011964132 @default.
• W2009781900 cites W2023815739 @default.
• W2009781900 cites W2024112744 @default.
• W2009781900 cites W2036454015 @default.
• W2009781900 cites W2055847168 @default.
• W2009781900 cites W2070643713 @default.
• W2009781900 cites W2081073335 @default.
• W2009781900 cites W2086443301 @default.
• W2009781900 cites W2096459479 @default.
• W2009781900 cites W2100730818 @default.
• W2009781900 cites W2100762651 @default.
• W2009781900 cites W2106213640 @default.
• W2009781900 cites W2107522704 @default.
• W2009781900 cites W2109973294 @default.
• W2009781900 cites W2123622204 @default.
• W2009781900 cites W2137276105 @default.
• W2009781900 cites W3111388598 @default.
• W2009781900 cites W4248110985 @default.
• W2009781900 doi "https://doi.org/10.1016/j.jtcvs.2009.10.059" @default.
• W2009781900 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20176215" @default.
• W2009781900 hasPublicationYear "2010" @default.
• W2009781900 type Work @default.
• W2009781900 sameAs 2009781900 @default.
• W2009781900 citedByCount "13" @default.
• W2009781900 countsByYear W20097819002012 @default.
• W2009781900 countsByYear W20097819002013 @default.
• W2009781900 countsByYear W20097819002014 @default.
• W2009781900 countsByYear W20097819002015 @default.
• W2009781900 countsByYear W20097819002016 @default.
• W2009781900 countsByYear W20097819002018 @default.
• W2009781900 countsByYear W20097819002019 @default.
• W2009781900 countsByYear W20097819002020 @default.
• W2009781900 countsByYear W20097819002022 @default.
• W2009781900 crossrefType "journal-article" @default.
• W2009781900 hasAuthorship W2009781900A5010710044 @default.
• W2009781900 hasAuthorship W2009781900A5011287213 @default.
• W2009781900 hasAuthorship W2009781900A5026657861 @default.
• W2009781900 hasAuthorship W2009781900A5036332989 @default.
• W2009781900 hasAuthorship W2009781900A5041469816 @default.
• W2009781900 hasAuthorship W2009781900A5053079459 @default.
• W2009781900 hasAuthorship W2009781900A5058653910 @default.
• W2009781900 hasAuthorship W2009781900A5072582612 @default.
• W2009781900 hasAuthorship W2009781900A5073141203 @default.
• W2009781900 hasAuthorship W2009781900A5091801351 @default.
• W2009781900 hasBestOaLocation W20097819001 @default.
• W2009781900 hasConcept C126322002 @default.
• W2009781900 hasConcept C158846371 @default.
• W2009781900 hasConcept C164705383 @default.
• W2009781900 hasConcept C178853913 @default.
• W2009781900 hasConcept C2778881276 @default.
• W2009781900 hasConcept C2780799893 @default.
• W2009781900 hasConcept C31174226 @default.
• W2009781900 hasConcept C42219234 @default.
• W2009781900 hasConcept C71924100 @default.
• W2009781900 hasConcept C84393581 @default.
• W2009781900 hasConcept C98274493 @default.
• W2009781900 hasConceptScore W2009781900C126322002 @default.
• W2009781900 hasConceptScore W2009781900C158846371 @default.
• W2009781900 hasConceptScore W2009781900C164705383 @default.
• W2009781900 hasConceptScore W2009781900C178853913 @default.
• W2009781900 hasConceptScore W2009781900C2778881276 @default.
• W2009781900 hasConceptScore W2009781900C2780799893 @default.
• W2009781900 hasConceptScore W2009781900C31174226 @default.
• W2009781900 hasConceptScore W2009781900C42219234 @default.
• W2009781900 hasConceptScore W2009781900C71924100 @default.
• W2009781900 hasConceptScore W2009781900C84393581 @default.
• W2009781900 hasConceptScore W2009781900C98274493 @default.
• W2009781900 hasIssue "3" @default.
• W2009781900 hasLocation W20097819001 @default.
• W2009781900 hasLocation W20097819002 @default.
• W2009781900 hasOpenAccess W2009781900 @default.

• next